Clearance Summary
ACCU-CHEK CONNECT DIABETES MANAGEMENT APP received FDA 510(k) clearance under submission number K141929, sponsored by Roche Diagnostics Corporation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 2015-03-16.
- Submission: K141929
- Applicant / Sponsor: Roche Diagnostics Corporation
- Clearance pathway: Traditional
- Review panel: Anesthesiology
- Device class: Class II
- Regulation citation: 21 CFR 868.1890
- Decision date: 2015-03-16
Classification & Regulation
This clearance is catalogued under FDA product code NDC and 21 CFR 868.1890, within the Anesthesiology review panel as a Class II device.